- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
强势上涨过程中，可逢低买进，暂不考虑做空。
- 中期趋势：
正处于反弹阶段。
- 长期趋势：
已有1家主力机构披露2026-06-30报告期持股数据，持仓量总计45.44万股，占流通A股0.03%
- 波段诊断：
-
技术面诊股
平均成本
近期的平均成本为12.40元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"12.40","date":1784448108,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势跑赢大盘，跑赢行业平均水平。
[{"date":"2026.07.20","stock":"3.99","trade":"0.38","ind":"-0.71"},{"date":"2026.07.17","stock":"-5.32","trade":"-7.01","ind":"-5.40"},{"date":"2026.07.16","stock":"3.85","trade":"0.36","ind":"-1.97"},{"date":"2026.07.15","stock":"3.48","trade":"2.67","ind":"-0.97"},{"date":"2026.07.14","stock":"1.34","trade":"2.74","ind":"2.77"},{"date":"2026.07.13","stock":"-2.22","trade":"-1.36","ind":"-3.48"},{"date":"2026.07.10","stock":"7.04","trade":"3.33","ind":"-2.29"},{"date":"2026.07.09","stock":"-0.52","trade":"0.10","ind":"3.07"},{"date":"2026.07.08","stock":"-1.55","trade":"-1.54","ind":"-1.87"},{"date":"2026.07.07","stock":"-4.99","trade":"-4.28","ind":"-1.24"},{"date":"2026.07.06","stock":"0.41","trade":"1.41","ind":"-1.16"},{"date":"2026.07.03","stock":"0.00","trade":"1.88","ind":"0.64"},{"date":"2026.07.02","stock":"-1.62","trade":"-0.24","ind":"-3.85"},{"date":"2026.07.01","stock":"5.82","trade":"4.33","ind":"-0.53"},{"date":"2026.06.30","stock":"-2.75","trade":"-0.54","ind":"2.48"},{"date":"2026.06.29","stock":"5.62","trade":"7.43","ind":"0.19"},{"date":"2026.06.26","stock":"-5.17","trade":"-3.87","ind":"-3.44"},{"date":"2026.06.25","stock":"0.42","trade":"-1.00","ind":"1.82"},{"date":"2026.06.24","stock":"-3.71","trade":"-1.03","ind":"1.24"},{"date":"2026.06.23","stock":"0.81","trade":"2.96","ind":"-3.17"},{"date":"2026.06.22","stock":"0.82","trade":"-0.76","ind":"2.13"}]
智飞生物,深证成指,生物制品指数
压力支撑
该股压力位为12.38元，支撑位为12.02元。
[{"text":"\u538b\u529b\u4f4d","value":"12.38","date":1784476800,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"12.02","date":1784476800,"color":"0x0b52a1"}]
多空趋势
空头行情中，目前正处于反弹阶段，投资者可适当关注。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：5.0资金面打败了63%的股票
主力控盘前10的股票
行业资金
生物制品行业， 近5日资金总体呈流入状态，投资者可考虑关注该行业的个股。
更新时间：07月20日 20:30
| 机构今日流向(万元) | 1554.67 | 机构5日流向(万元) | 3200.10 |
| 机构10日流向(万元) | 1619.68 | 机构20日流向(万元) | 3397.30 |
机构持仓
2026-06-30 与 2025-12-31 相比，主力机构持仓量减少27789.65万股，其中基金净增仓1家，主力净减仓383家，暂未发现中长期投资价值。
截止2026-06-30，共1家主力机构（基金1家），持仓量总计45.44万股，占流通A股0.03%
其中，基金持仓与2025-12-31相比：
增仓：1家 ，增持 2.87万股
减仓：0家 ，减持 0万股
新出现在主力名单中：0家 ，持有万股
从主力名单中消失：383家 ，原持有27792.52万股
其中，基金持仓与2025-12-31相比：
增仓：1家 ，增持 2.87万股
减仓：0家 ，减持 0万股
新出现在主力名单中：0家 ，持有万股
从主力名单中消失：383家 ，原持有27792.52万股
消息面诊股
诊断结果：5.3消息面打败了27%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 智飞生物：7月17日获融资买入2288.72万元
2026-07-20 - 智飞生物：公司现已形成北京智飞绿竹、安徽智飞龙科马
2026-07-17 - 智飞生物：自去年以来，公司聚焦生产经营稳健发展，持
2026-07-17 - 智飞生物：公司自主产品涵盖预防流脑、流感等传染病的
2026-07-17 - 智飞生物：积极布局大健康领域，促进前沿生物医药、先
2026-07-17 - 智飞生物：7月16日获融资买入3238.83万元
2026-07-17 - 2026 疫苗行业分析：多联苗、HPV 疫苗市场规
2026-07-16 - 智飞生物：7月15日获融资买入2951.45万元
2026-07-16 - 智飞生物：7月14日获融资买入1685.48万元
2026-07-15 - 智飞生物：7月13日获融资买入1786.76万元
2026-07-14
消息列表
| 一般消息 | 重大事项 | 公司股东股份解押 | 2026-06-25 |
| 利空 | 重大事项 | 公司违规：处罚类型 | 2026-05-08 |
| 一般消息 | 股东大会 | 年度股东大会 | 2026-04-28 |
| 一般消息 | 分红转增 | 不分配不转增 | 2026-04-28 |
| 一般消息 | 重大事项 | 关联交易 | 2026-04-28 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2026-03-17 |
| 利空 | 业绩预告 | 业绩预亏 | 2026-01-12 |
| 一般消息 | 重大事项 | 关联交易 | 2026-01-05 |
| 一般消息 | 高管变动 | 取消监事会 | 2025-11-18 |
| 一般消息 | 高管变动 | 因公司治理结构及内部工作调整 | 2025-10-28 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-19 |
| 一般消息 | 重大事项 | 关联交易 | 2025-08-19 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 0条 | 0条 | 0条 |
| 利空 | 2条 | 0条 | 2条 |
行业面诊股
诊断结果：6.3行业面打败了86%的股票
生物制品行业最新资金流向
近10日来该行业走势不明显，跑赢大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势不明显，跑赢大盘。
[{"date":"2026.07.20","price":"-0.71","value":"0.38"},{"date":"2026.07.17","price":"-5.40","value":"-7.01"},{"date":"2026.07.16","price":"-1.97","value":"0.36"},{"date":"2026.07.15","price":"-0.97","value":"2.67"},{"date":"2026.07.14","price":"2.77","value":"2.74"},{"date":"2026.07.13","price":"-3.48","value":"-1.36"},{"date":"2026.07.10","price":"-2.29","value":"3.33"},{"date":"2026.07.09","price":"3.07","value":"0.10"},{"date":"2026.07.08","price":"-1.87","value":"-1.54"},{"date":"2026.07.07","price":"-1.24","value":"-4.28"},{"date":"2026.07.06","price":"-1.16","value":"1.41"},{"date":"2026.07.03","price":"0.64","value":"1.88"},{"date":"2026.07.02","price":"-3.85","value":"-0.24"},{"date":"2026.07.01","price":"-0.53","value":"4.33"},{"date":"2026.06.30","price":"2.48","value":"-0.54"},{"date":"2026.06.29","price":"0.19","value":"7.43"},{"date":"2026.06.26","price":"-3.44","value":"-3.87"},{"date":"2026.06.25","price":"1.82","value":"-1.00"},{"date":"2026.06.24","price":"1.24","value":"-1.03"},{"date":"2026.06.23","price":"-3.17","value":"2.96"},{"date":"2026.06.22","price":"2.13","value":"-0.76"}]
深证成指,生物制品行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 艾迪药业 | 33.39% | 11.51% | 6.7分 |
| 2 | 百普赛斯 | 30.97% | 4.64% | 6.5分 |
| 3 | 迈威生物 | 22.93% | 4.95% | 6.0分 |
| 4 | 君实生物 | 18.94% | -3.45% | 5.8分 |
| 5 | 义翘神州 | 18.44% | 1.19% | 6.3分 |
| 6 | 康辰药业 | 17.89% | -1.16% | 6.7分 |
| 8 | 智翔金泰 | 16.63% | 2.99% | 5.5分 |
| 10 | 甘李药业 | 15.13% | 0.44% | 6.3分 |
| 12 | 禾元生物 | 14.50% | 4.29% | 5.6分 |
| 14 | 赛升药业 | 14.16% | -3.31% | 5.0分 |
| 16 | 长春高新 | 12.81% | 5.89% | 5.8分 |
| 18 | 特宝生物 | 11.75% | 7.82% | 6.6分 |
| 20 | 神州细胞 | 10.56% | 1.93% | 6.1分 |
| 22 | 康泰生物 | 8.65% | 4.63% | 6.2分 |
| 24 | 荣昌生物 | 7.99% | -7.09% | 6.2分 |
| 26 | 三生国健 | 6.62% | -13.65% | 5.3分 |
| 28 | 百奥泰 | 6.37% | -0.11% | 5.6分 |
| 30 | 华兰生物 | 5.38% | 3.17% | 6.0分 |
| 32 | 西藏药业 | 3.96% | 1.65% | 6.2分 |
| 34 | 智飞生物 | 3.66% | 7.23% | 6.0分 |
| 36 | 博雅生物 | 3.34% | 7.13% | 6.0分 |
| 38 | 辽宁成大 | 2.42% | 10.00% | 6.3分 |
| 40 | 成大生物 | 0.50% | 2.25% | 5.1分 |
| 42 | - | -0.49% | -4.11% | 分 |
| 44 | 优宁维 | -1.22% | -0.54% | 5.3分 |
| 46 | 卫光生物 | -4.34% | -0.62% | 5.0分 |
| 48 | 金迪克 | -5.19% | -6.29% | 4.3分 |
| 50 | *ST未名 | -10.19% | -7.71% | 4.8分 |
| 52 | 万泽股份 | -21.37% | -5.78% | 5.0分 |
| 54 | 赛伦生物 | -32.67% | -19.14% | 4.1分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2026-03-31 ]公司经营
盈利能力：较强，高于行业平均，两项指标的行业排名分别为 45/71 ， 46/71。
[{"date":"2026-03-31","value":"-2.48","vol":"-6.01"},{"date":"2025-12-31","value":"-63.06","vol":"-12.99"},{"date":"2025-09-30","value":"-4.42","vol":"-10.09"},{"date":"2025-06-30","value":"-1.96","vol":"-0.66"},{"date":"2025-03-31","value":"-1.05","vol":"-0.34"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
-2.48 | -63.06 | -4.42 | -1.96 | -1.05 |
| 行业(%) | -6.01 | -12.99 | -10.09 | -0.66 | -0.34 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"29.16","vol":"61.43"},{"date":"2025-12-31","value":"7.84","vol":"66.53"},{"date":"2025-09-30","value":"21.82","vol":"67.71"},{"date":"2025-06-30","value":"28.30","vol":"66.67"},{"date":"2025-03-31","value":"32.01","vol":"38.38"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
29.16 | 7.84 | 21.82 | 28.30 | 32.01 |
| 行业(%) | 61.43 | 66.53 | 67.71 | 66.67 | 38.38 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 37/71 ， 28/71。
[{"date":"2026-03-31","value":"-8.64","vol":"297.05"},{"date":"2025-12-31","value":"-65.61","vol":"39.85"},{"date":"2025-09-30","value":"-66.45","vol":"45.81"},{"date":"2025-06-30","value":"-73.05","vol":"6902.14"},{"date":"2025-03-31","value":"-79.39","vol":"6125.11"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-8.64 | -65.61 | -66.45 | -73.05 | -79.39 |
| 行业(%) | 297.05 | 39.85 | 45.81 | 6902.14 | 6125.11 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"-18.79","vol":"74.22"},{"date":"2025-12-31","value":"-846.42","vol":"33.79"},{"date":"2025-09-30","value":"-162.57","vol":"45.67"},{"date":"2025-06-30","value":"-126.62","vol":"5.21"},{"date":"2025-03-31","value":"-121.91","vol":"-8.79"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-18.79 | -846.42 | -162.57 | -126.62 | -121.91 |
| 行业(%) | 74.22 | 33.79 | 45.67 | 5.21 | -8.79 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：较强，高于行业平均，两项指标的行业排名分别为 17/71 ， 10/71。
[{"date":"2026-03-31","value":"0.07","vol":"0.06"},{"date":"2025-12-31","value":"0.22","vol":"0.29"},{"date":"2025-09-30","value":"0.16","vol":"0.21"},{"date":"2025-06-30","value":"0.10","vol":"0.13"},{"date":"2025-03-31","value":"0.05","vol":"0.06"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.07 | 0.22 | 0.16 | 0.10 | 0.05 |
| 行业(次) | 0.06 | 0.29 | 0.21 | 0.13 | 0.06 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"0.36","vol":"0.29"},{"date":"2025-12-31","value":"0.61","vol":"1.29"},{"date":"2025-09-30","value":"0.28","vol":"0.90"},{"date":"2025-06-30","value":"0.16","vol":"0.55"},{"date":"2025-03-31","value":"0.07","vol":"0.25"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.36 | 0.61 | 0.28 | 0.16 | 0.07 |
| 行业(次) | 0.29 | 1.29 | 0.90 | 0.55 | 0.25 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2026-03-31","value":"12.93","vol":"-78.67"},{"date":"2025-12-31","value":"166.07","vol":"12.85"},{"date":"2025-09-30","value":"52.25","vol":"0.21"},{"date":"2025-06-30","value":"49.00","vol":"-1377.65"},{"date":"2025-03-31","value":"12.93","vol":"-2083.82"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 12.93 | 166.07 | 52.25 | 49.00 | 12.93 |
| 行业 | -78.67 | 12.85 | 0.21 | -1377.65 | -2083.82 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"1.16","vol":"1.74"},{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"1.00","vol":"1.55"},{"date":"2025-03-31","value":"","vol":"0.00"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 1.16 | - | 1.00 | - |
| 行业 | 0.00 | 1.74 | 0.00 | 1.55 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，居行业前列，两项指标的行业排名分别为 19/71 ， 24/71。
[{"date":"2026-03-31","value":"3.14","vol":"6.66"},{"date":"2025-12-31","value":"1.53","vol":"5.80"},{"date":"2025-09-30","value":"2.78","vol":"6.07"},{"date":"2025-06-30","value":"2.45","vol":"6.57"},{"date":"2025-03-31","value":"2.30","vol":"7.73"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 流动比率 |
3.14 | 1.53 | 2.78 | 2.45 | 2.30 |
| 行业 | 6.66 | 5.80 | 6.07 | 6.57 | 7.73 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"2.43","vol":"5.14"},{"date":"2025-12-31","value":"1.12","vol":"4.43"},{"date":"2025-09-30","value":"1.21","vol":"4.89"},{"date":"2025-06-30","value":"1.06","vol":"5.24"},{"date":"2025-03-31","value":"1.03","vol":"6.33"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 速动比率 |
2.43 | 1.12 | 1.21 | 1.06 | 1.03 |
| 行业 | 5.14 | 4.43 | 4.89 | 5.24 | 6.33 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 8/71 ， 14/71。
[{"date":"2026-03-31","value":"45.99","vol":"28.78"},{"date":"2025-12-31","value":"49.22","vol":"28.75"},{"date":"2025-09-30","value":"36.42","vol":"28.02"},{"date":"2025-06-30","value":"34.18","vol":"26.19"},{"date":"2025-03-31","value":"36.85","vol":"26.65"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
45.99 | 49.22 | 36.42 | 34.18 | 36.85 |
| 行业(%) | 28.78 | 28.75 | 28.02 | 26.19 | 26.65 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"0.87","vol":"2.54"},{"date":"2025-12-31","value":"0.99","vol":"1.42"},{"date":"2025-09-30","value":"0.58","vol":"0.58"},{"date":"2025-06-30","value":"0.52","vol":"1.11"},{"date":"2025-03-31","value":"0.58","vol":"0.80"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.87 | 0.99 | 0.58 | 0.52 | 0.58 |
| 行业(%) | 2.54 | 1.42 | 0.58 | 1.11 | 0.80 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
机构预测该股2026年每股收益与前一年相同，长期投资价值一般。
[{"date":"2022","yellowRectValue":"75.39","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"81.08","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"20.06","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"-147.23","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"-12.52","blueLineValue":"-0.52","type":"YC"}]